Congenital and Childhood myeloproliferative disorders with eosinophilia responsive to imatinib
Shirley Abraham(University of New Mexico), Mark Fluchel(University of Utah), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), Jeffrey Jacobsen(St. Jude Children's Research Hospital), Jeffrey D. Hancock(University of Utah)
Cited by 15
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484
A genetic mechanism for Tibetan high-altitude adaptation
|Nature Genetics|2014|441
The genomic landscape of juvenile myelomonocytic leukemia
|Nature Genetics|2015|310